Cardiac effect of thyrotoxicosis in acromegaly

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 4, 2000, Pages 1426-1432

  Marzullo, Paolo ^a   Cuocolo, Alberto ^a,b   Ferone, Diego ^a   Pivonello, Rosario ^a   Salvatore, Marco ^a   Lombardi, Gaetano ^a   Colao, Annamaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY RISK; EXERCISE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTHYROIDISM; PRIORITY JOURNAL; THYROTOXICOSIS;

ACROMEGALY; ANTITHYROID AGENTS; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMAN GROWTH HORMONE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INSULIN-LIKE GROWTH FACTOR I; IODINE RADIOISOTOPES; LONGITUDINAL STUDIES; MALE; METHIMAZOLE; MIDDLE AGED; RADIONUCLIDE ANGIOGRAPHY; THYROTOXICOSIS; VENTRICULAR FUNCTION, LEFT;

EID: 0034458338     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.4.1426     Document Type: Article

References (41)

1. Anatomie pathologique, lesions et troubles cardiovasculaires de l'acromegalie
2. Collections from the unpublished papers of the late Caleb Hilliel Parry
3. Growth hormone and prolactin excess
4. Acromegaly
5. Growth hormone and the heart
6. Thyrotoxicosis and the heart
7. Acromegaly
8. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984
9. An audit of outcome of treatment in acromegaly
10. Mortality and cancer incidence in acromegaly: A retrospective cohort study
11. Echocardiographic assessment of cardiac anatomy and function in acromegalic patient
12. Subclinical cardiac dysfunction in acromegaly: Evidence for a specific disease of heart muscle
13. Evidence for biventricular involvement in acromegaly: A Doppler echocardiographic study
14. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly
15. Cardiac involvement in acromegaly: Specific myocardiopathy or consequence of systemic hypertension
16. Impact of patient's age and disease duration on cardiac performance in acromegaly: A radionuclide angiography study
17. The nature and prognosis of heart disease in thyrotoxicosis
18. Cardiac performance in thyrotoxicosis: Analysis of 10 untreated patients
19. The nature and prognosis of thyrotoxic heart disease
20. Rest and exercise left ventricular ejection fraction before and after therapy in young adults with hyperthyroidism and hypothyroidism
21. Thyroid hormone and high blood pressure
22. Enhanced left ventricular diastolic function in hyperthyroidism: Noninvasive assessment and response to treatment
23. Thyrotoxicosis and the heart
24. Congestive heart failure due to reversible cardiomyopathy in patients with hyperthyroidism
25. Thyroid hormone and cardiovascular disease
26. Struma thyreoidale autonomie und hyperthyreose bei akromegalie
27. Thyroid volume and serum thyroglobulin levels in patients with acromegaly: Correlation with plasma insulin-like growth factor I levels
28. Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly
29. The thyroid gland in acromegaly: An ultrasonographic study
30. The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: Results of a survey of echocardiographic measurements
31. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization and comparison to other methods
32. Left ventricular peak ejection rate, filling rate and ejection fraction: Frame requirements at rest and exercise
33. Preserved thyroidal secretion of thyroxine in acromegalic patients with suppressed hypophyseal secretion of thyrotrophin
34. Thyroid nodules in Graves' disease: Classification, characterization, and response to treatment
35. Effects of one year treatment with octreotide on cardiac performance in acromegaly
36. Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly
37. Cardiac effects of slowrelease lanreotide, a slow-release somatostatin analog, in acromegalic patients
38. Abnormal left ventricular function in hyperthyroidism: Evidence for a possible reversible cardiomyopathy
39. Left ventricular systolic and diastolic function in hyperthyroidism
40. 3) treatment after surgery for complex congenital heart disease in infants and children
41. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy